Amendments to IFRS 3 endorsed for use in the EU
On 21 April 2020, Amendments to IFRS 3 Definition of business were endorsed by the European Commission for use in the European Union. The EU effective date is the same as the IASB’s effective date.
On 21 April 2020, Amendments to IFRS 3 Definition of business were endorsed by the European Commission for use in the European Union. The EU effective date is the same as the IASB’s effective date.
Amendment No. 163/2020 Coll. to the Civil Code has gone through the legislative process and is signed by the President. The amendment aims to remedy partial deficiencies identified in practice. The amendment co…
In early April, the Technology Agency of the Czech Republic announced a new call aimed at the support of applied research, experimental development and innovations in the area of transportation – TRANSPORTATION…
In early April, several calls and public tenders from various programmes were announced in response to the current situation caused by COVID-19. More details about Technology COVID-19, Czech Rise Up – Smart Mea…
The Ministry of Finance proposes adopting a series of tax measures in the area of real property, from which it hopes to set the market in motion and, in the long term, also improve the availability of one’s own…
The European Financial Reporting Advisory Group (EFRAG) updated its report showing the status of endorsement of each IFRS, including standards, interpretations, and amendments, most recently on 23 January 2020.
On 27 March 2020, the International Accounting Standards Board (IASB) published a document responding to questions regarding the application of IFRS 9 Financial Instruments during the period of increased econom…
On 17 April 2020, the International Accounting Standards Board (IASB) decided during its supplementary meeting concerning COVID-19-related matters to amend IFRS 16 by the end of May 2020.
In the last issue of the Accounting news we informed you about the publication IFRS in Focus – Accounting considerations related to the coronavirus disease 2019, which was issued in March 2020 by Deloitte. Due …